Published in Biochem Biophys Res Commun on November 21, 2003
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer (2009) 3.52
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32
Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch (2005) 1.07
Dickkopfs and Wnt/β-catenin signalling in liver cancer. World J Clin Oncol (2011) 0.94
Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus. Virchows Arch (2010) 0.89
Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig Dis Sci (2007) 0.88
Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. World J Gastroenterol (2010) 0.86
Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma. PLoS One (2013) 0.84
Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer. PLoS One (2014) 0.82
A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. BMC Cancer (2009) 0.79
Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis. Dig Dis Sci (2012) 0.77
Involvement of liver-intestine cadherin in cancer progression. Med Mol Morphol (2013) 0.76
Cadherin 17 is a sensitive and specific marker for metanephric adenoma. Am J Surg Pathol (2015) 0.75
Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer. Oncotarget (2016) 0.75
Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma. Cell Oncol (Dordr) (2017) 0.75
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell (2006) 12.72
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell (2008) 5.47
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer (2009) 3.52
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet (2006) 2.96
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology (2006) 2.78
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun (2010) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol (2010) 1.69
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One (2011) 1.56
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53
Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther (2008) 1.53
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open (2012) 1.50
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer (2009) 1.49
CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology (2012) 1.48
Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Am J Gastroenterol (2004) 1.45
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics (2007) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36
Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34
Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res (2005) 1.32
Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31
Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (2001) 1.30
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res (2005) 1.29
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. J Hepatol (2007) 1.28
Factors affecting conversion of laparoscopic cholecystectomy to open surgery. Arch Surg (1996) 1.28
Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg (1996) 1.27
Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease. FEBS Lett (2006) 1.27
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One (2011) 1.26
Applicability of intraoperative parathyroid hormone assay during thyroidectomy. Ann Surg (2002) 1.26
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26
Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res (2006) 1.25
Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25
Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets (2010) 1.24
Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer (1998) 1.24
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol (2000) 1.24
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
Biliary complications during liver resection. World J Surg (2001) 1.23
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22
Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg (1998) 1.22
Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc (1999) 1.19
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res (Phila) (2012) 1.16
Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg (2001) 1.15
Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res (2005) 1.15
Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg (2001) 1.15
Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods (2005) 1.14
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrob Agents Chemother (1985) 1.13
Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg (2009) 1.13
Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun (2004) 1.13
Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg (1990) 1.12